Portfolio Design Labs’s CVS Health CVS Stock Holding History

Portfolio Design Labs’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-24,731	Closed	-$1.46M	–	137
2024 Q2	$1.46M	Buy	24,731 +4,553	+23%	+$285K	0.45%	78
2024 Q1	$1.61M	Buy	+20,178	New	+$1.54M	0.54%	79

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Portfolio Design Labs's CVS Position: Q3 2024 in Review

Portfolio Design Labs sold out of CVS Health (CVS) in Q3 2024, closing a stake of 24,731 shares — an estimated $1.46M sold.

Portfolio Design Labs first reported a position in CVS in Q1 2024 and held it in 2 quarters. The position peaked at $1.61M in Q1 2024. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Portfolio Design Labs reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Portfolio Design Labs sold 24,731 CVS Health shares in Q3 2024, an estimated $1.46M.
Portfolio Design Labs first reported a position in CVS Health in Q1 2024 and held it in 2 quarters.
Portfolio Design Labs's CVS Health position peaked at $1.61M in Q1 2024.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Portfolio Design Labs's 13F filing for Q3 2024, filed 8 Nov 2024.